Medlab Middle East 2025 Opens with Groundbreaking Innovations
|
By LabMedica International staff writers Posted on 03 Feb 2025 |

The 24th edition of Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, is being held at Dubai World Trade Centre from 3-6 February. Organized by Informa Markets (London, UK), the event themed ‘Empowering today’s medical labs for tomorrow’s future’ features over 800 exhibitors from 40 countries, with 20,000 visitors exploring the latest technology and updates for the laboratory industry. Medlab Middle East showcases the latest innovations and technologies across eight dynamic product categories, which include disposables and consumer goods, emergency medicine, imaging and diagnostics, healthcare and general services, IT, laboratory, medical equipment and devices, and pharma and nutrition.
The 24th edition builds on the success of Medlab Middle East 2024 when the event generated an estimated business value of USD 670 million, fueling medical laboratory growth across the Middle East and beyond. The event features the most prominent names in the industry, with key exhibitors showcasing their innovations including Snibe, PureLab, World Data Exchange, Merck and Abbott. The world’s only multidisciplinary congress in the medical laboratory industry, the Medlab Middle East Congress returns with 12 CME-accredited conferences in Lab Management, Clinical Chemistry, Lab Quality, Hematology, Clinical Microbiology, Molecular Diagnostics, Blood Transfusion Medicine and Cellular Therapy, Histopathology, Lab Sustainability and Immunology. A new Lab Automation conference debuts this year, designed to explore the transformative impact of automation and IT workflows on laboratory operations.
The Congress features 150 local and international speakers and 60 VIP guests and is expected to draw over 4,000 delegates from the medical and laboratory fields. Key topics explored at the event include ‘The role of laboratory leadership to prepare laboratories for outbreak detection’, ‘Advances in stem cell therapy’ and ‘The past and the future for biomedical sciences and career options for the next generation’. Medlab Middle East 2025 is introducing two new leadership forums dedicated to women’s health and precision medicine. The Women’s Health Leadership Forum, held on the opening day of Medlab Middle East, aims to enhance women’s health through laboratory diagnostics. The event showcases cutting-edge innovations, addresses key challenges and uncovers collaboration opportunities that will enhance diagnostic capabilities for addressing women’s health needs.
The Precision Medicine Leadership Forum, featuring precision medicine experts, aims to offer insights from top experts in precision medicine, fostering a dialogue around cutting-edge innovations in genetics, personalized healthcare and new targeted therapies shaping the future of patient care. The program includes sessions on how genetic data is being integrated into treatment plans and the impact of precision medicine on improving patient care, among several other key topics in the precision medicine field. Also new for the 2025 edition, the Global Lab Leaders Breakfast Forum unites Medlab portfolio global advisers, scientific chairs, international partners and stakeholders in an exclusive, invitation-only dialogue, concentrating on topics that are crucial to advancing laboratory practices worldwide. The GCC Lab Leaders Breakfast Forum will see a gathering of officials, experts, and specialists from both public and private sector laboratories, as well as national standardization bodies across the GCC region. The event aims to foster collaboration and open dialogue on critical topics, including laboratory management, quality assurance, and proficiency testing. The ABCHealth Session at Medlab Middle East explores the transformative role of AI and advanced technologies in reshaping diagnostic business models across Africa.
“The 2025 edition of Medlab Middle East promises to be a landmark event which spotlights cutting-edge advancements and sustainable practices in laboratory medicine,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare. “The event offers a unique opportunity to connect with a diverse range of companies and professionals in the medical laboratory industry, opening doors to new networks and opportunities for growth.”
Latest MEDLAB 2025 News
- Medlab Middle East Rebranded to WHX Labs Dubai
- BIOBASE Showcases Comprehensive Range of Laboratory Solutions
- Dymind Presents Advanced Automatic Hematology Analysis Line
- BioPerfectus Presents Latest Solutions for Women's Health and Infectious Disease Diagnosis
- YHLO Unveils Total Laboratory Automation System for Elevated Laboratory Efficiency
- Vazyme Showcases Cutting-Edge Microfluidic Solutions for Precise and Efficient Laboratory Workflows
- Erba Unveils New H 7100 Advanced Hematology Analyzer
- HUMAN Diagnostics Launches Next Generation Clinical Chemistry Instruments
- Tianlong Presents Advanced Instruments and Cutting-Edge Reagents
- Mindray Presents Range of IVD Total Solutions for Laboratories of All Sizes
- DRG Unveils Innovative Traumatic Brain Injury (TBI) Test Panel
- Fapon Presents Comprehensive Range of One-Stop IVD Solutions
- Anbio Biotechnology Showcases Cutting-Edge Diagnostic Solutions
- Sysmex Showcases Latest Laboratory Innovations and Technologies
- Sansure Presents Advanced Diagnostic Solutions
- Snibe Demonstrates Cutting-Edge Diagnostic Solutions
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more








